Comprehensive metabolomic characterization of coronary artery diseases
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
With the support by the National Natural Science Foundation of China,the research team led by Prof.Qi Lianwen (齐炼文) at the State Key Laboratory of Natural Medicines,China Pharmaceutical University,uncovered the disturbed metabolic pathways to assess the diagnostic value of metabolomics-based biomarkers in different types of coronary artery disease (CAD),which was published in Journal of the American College of Cardiology (2016,68(12):1281-1293).